Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $367.0700 (-1.66%) ($363.9900 - $373.8900) on Tue. Apr. 11, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.71% (three month average) | RSI | 52 | Latest Price | $367.0700(-1.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN declines -0.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -0.855% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.855% (StdDev 1.71%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $380.29 | 5 Day Moving Average | $375.54(-2.26%) | 10 Day Moving Average | $380.74(-3.59%) | 20 Day Moving Average | $380.29(-3.48%) | To recent high | -7.7% | To recent low | 7.7% | Market Cap | $38.92b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |